GGrantIndex
Sort

53,477 grants matching addiction

Research Training Program in Substance Abuse Prevention

$372,691
Jacob K Tebes · Yale University · T32 · FY2017 · DA

High content analgesic screening from human nociceptors

$372,687
Benedict J Kolber · University Of Texas Dallas · R33 · FY2024 · AT

Amoeboid Membrane Dynamics in Prostate Cancer

$372,685
Michael R Freeman · Cedars-Sinai Medical Center · R01 · FY2013 · CA

Mechanisms of nicotine reinforcement in mice

$372,674
Paul J Kenny · Scripps Research Institute, The · R01 · FY2011 · DA

Hypocretin/Orexin Regulation of Dopamine Signaling and Cocaine Reinforcement

$372,658
Rodrigo A. Espaã‘a · Drexel University · R01 · FY2018 · DA

Cognitive Control, Working Memory and Prefrontal Cortex

$372,591
Mark D'esposito · University Of California Berkeley · R01 · FY2015 · MH

The Neurotrophic Factor GDNF and Alcohol Addiction

$372,589
Ernest Gallo Clinic And Research Center · R01 · FY2005 · AA

Linking Services to Patient Needs for Improved Outcomes

$372,589
Treatment Research Institute, Inc. (Tri) · R01 · FY2004 · DA

Neuroimaging of Nicotine Dependence, Depression and Emotion Regulation

$372,585
Brett Froeliger · Medical University Of South Carolina · R01 · FY2014 · DA

Improving adolescent health by assessing in-session communication patterns

$372,559
Jon M. Houck · University Of New Mexico · R01 · FY2016 · MD

Neural Correlates of Avoidance Learning in Substance Abuse

$372,549
Jody L Tanabe · University Of Colorado Denver · R01 · FY2011 · DA

Mechanisms of TNFa Enhancement of Nicotinic Receptor Upregulation

$372,488
Lorise C Gahring · University Of Utah · R01 · FY2010 · DA

Brain Circuits of Outcome-dependent vs. Habitual Avoidance

$372,483
Christopher Kenneth Cain · New York University School Of Medicine · R01 · FY2018 · MH

OPTICAL NEUROMODULATION TECHNOLOGY FOR LONG TIMESCALES

$372,453
Karl Alexander Deisseroth · Stanford University · R01 · FY2013 · MH

Neural-Glial Interactions and Opioid Abuse: Modulation by Early-Life Experience

$372,438
Staci D Bilbo · Massachusetts General Hospital · R01 · FY2017 · DA

Psychological and Cognitive Mechanisms Underlying Sexual Compulsivity and HIV Ris

$372,424
Michael H Miner · University Of Minnesota · R01 · FY2011 · MH

Translational control of LTP

$372,414
Emmanuel Manuel Landau · Icahn School Of Medicine At Mount Sinai · R01 · FY2006 · DA

Chemical Modulators of the PIEZO2 Mechanoreceptor for the Study and Treatment of Pain

$372,414
Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR

Adenylyl Cyclase 1 (AC1) Inhibitors as Opioid Alternatives for Chronic and Inflammatory Pain

$372,414
Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR

High Throughput Screen to Identify Glutamate Carboxypeptidase II (GCPII) Brain-Penetrable-Inhibitors for the Treatment of Pain

$372,414
Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR

Optimization of Allosteric Regulators of the NaV1.7 Sodium Channel for Chemotherapy-induced Peripheral Neuropathy (CIPN)

$372,414
Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR

Development of Gpr151 Modulators for the Treatment of Opioid Dependence

$372,414
Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR

Targeting -opioid Receptor-Galanin Gal1 Receptor Heterodimers for the Treatment of Opioid Use Disorder (OUD)

$372,414
Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR

Mechanisms of Neuronal Specific Transcription

$372,413
Grace B Gill · Harvard Medical School · R01 · FY2006 · HD

Npr1 Antagonists for Pain and Itch

$372,411
Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR